Skip to content

Use of transcranial random noise stimulation (tRNS) as an adjunct to reaching training in chronic stroke survivors with severe arm paresis: An exploratory pilot study.

The effect of reaching training with active transcranial random noise stimulation (tRNS) on arm function compared to reaching training with sham tRNS in people with chronic stroke and severe arm paresis.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000952640
Acronym
Nil.
Enrollment
8
Registered
2014-09-04
Start date
2014-09-22
Completion date
2014-11-03
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Stroke survivors with severe upper limb paresis have the poorest functional prognosis. There is growing evidence of the benefits of repetitive training to promote recovery of upper limb function. In addition, there is accumulating evidence that non-invasive brain stimulation techniques, such as tRNS, can augment activity within the cortical areas that are engaged during various forms of training. The aim of this study is to investigate the therapeutic and neuroplastic effects of combining repetitive training with tRNS in stroke survivors with chronic and severe upper limb paresis. A triple-blind randomised controlled pilot trial will be conducted. Ten stroke survivors will be randomly allocated to 4-weeks of SMART Arm training with active tRNS or sham-tRNS. To determine the clinical benefit, all participants will be assessed pre- and post-training and 2-months follow-up using a range of impairment, activity, participation and quality of life measures. To determine the structural (DTI) and functional (resting state fMRI) connectivity of cortical motor regions, all participants will undergo a 3T MRI pre- and post-training.

Interventions

The intervention group will receive 12 x 45-minute training sessions with a physiotherapist (trainer) over 4-weeks (3 sessions per week). Individualised training will involve repetitive and incrementally progressed task-oriented reaching in sitting. Participants will be instructed to push their arm along a linear slide at a comfortable speed while receiving real-time visual feedback of performance. To augment full range movement, electrical stimulation to muscles of the arm will be applied as re

The intervention group will receive 12 x 45-minute training sessions with a physiotherapist (trainer) over 4-weeks (3 sessions per week). Individualised training will involve repetitive and incrementally progressed task-oriented reaching in sitting. Participants will be instructed to push their arm along a linear slide at a comfortable speed while receiving real-time visual feedback of performance. To augment full range movement, electrical stimulation to muscles of the arm will be applied as required using the Empi 300PV unit (St Paul, MN, USA). Stimulation parameters will consist of a 1 second ascending ramp, and a 4 to 20 second duration of 200-sec pulse width biphasic stimulation at 35 Hz. All training will be recorded by the trainer in a logbook. Training will be combined with transcranial random noise stimulation (tRNS). Stimulation will occur for the first 5-seconds of each movement attempt to augment voluntary motor drive. Stimulation will be delivered by a battery-driven non-invasive brain stimulator (Neuroconn, Germany) through conductive rubber electrodes, placed in saline soaked sponges. The noise signal will contain all frequencies (101 – 640 Hz) up to half the sampling rate (1280 sps). The electrodes will be positioned over C3/C4 as per the 10/20 international system for EEG electrode placement: the stimulation electrode positioned over the ipsilesional primary motor cortex (M1) and the reference electrode positioned over the contralateral supra-orbital region. All tRNS parameters will be recorded in a separate log by an unblinded intervener. The stimulating unit will be placed out of sight of the participant and trainer at all times.

Sponsors

Dr Kathryn Hayward
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All participants will be first time adult (greater than 18 years) stroke survivors who are 6 to 24 months post stroke who demonstrate severe upper limb paresis (as indicated by a Motor Assessment Scale item 6 score of less than 4 out of a possible 6 points). A minimum level of active movement consistent with a triceps brachii score of 2- is required, along with the ability to understand single stage commands. All participants will not have participated in any rehabilitation services for their arm for at least 2-weeks prior to commencement of training.

Exclusion criteria

Exclusion criteria include: 1) any contraindications to tRNS or MRI, 2) presence of neurological conditions other than stroke e.g., Parkinson’s disease, or upper limb comorbidities that could limit functional recovery e.g., arthritis, 3) elbow contracture greater than 15 degrees, or 4) currently taking medication/s that could alter cortical excitability (e.g., antiepileptic medications, antidepressants) or have a presumed positive or negative effect on neural plasticity (e.g., dopamine, dexamphetamine).

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 10, 2026